Chemoinformaics analysis of CANNABICHROMEVARINIC-ACID
| Molecular Weight | 330.424 | nRot | 5 |
| Heavy Atom Molecular Weight | 304.216 | nRig | 14 |
| Exact Molecular Weight | 330.183 | nRing | 2 |
| Solubility: LogS | -3.176 | nHRing | 0 |
| Solubility: LogP | 5.557 | No. of Aliphatic Rings | 1 |
| Acid Count | 1 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 50 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 24 | No. of Aromatic Carbocycles | 1 |
| nHetero | 4 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 26 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 20 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 4 | No. of Arom Bond | 6 |
| nHA | 3 | APOL | 53.9446 |
| nHD | 3 | BPOL | 26.9514 |
| QED | 0.68 |
| Synth | 3.681 |
| Natural Product Likeliness | 2.313 |
| NR-PPAR-gamma | 0.948 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.02 |
| Pgp-sub | 0.002 |
| HIA | 0.009 |
| CACO-2 | -4.847 |
| MDCK | 0.0000107 |
| BBB | 0.019 |
| PPB | 0.992737 |
| VDSS | 1.122 |
| FU | 0.00921138 |
| CYP1A2-inh | 0.107 |
| CYP1A2-sub | 0.917 |
| CYP2c19-inh | 0.059 |
| CYP2c19-sub | 0.134 |
| CYP2c9-inh | 0.574 |
| CYP2c9-sub | 0.428 |
| CYP2d6-inh | 0.363 |
| CYP2d6-sub | 0.151 |
| CYP3a4-inh | 0.062 |
| CYP3a4-sub | 0.132 |
| CL | 1.038 |
| T12 | 0.285 |
| hERG | 0.033 |
| Ames | 0.021 |
| ROA | 0.402 |
| SkinSen | 0.086 |
| Carcinogencity | 0.174 |
| EI | 0.013 |
| Respiratory | 0.917 |
| NR-Aromatase | 0.025 |
| Antiviral | No |
| Prediction | 0.734806 |